Literature DB >> 17470625

Light chain deposition disease involving the airways: diagnosis by fibreoptic bronchoscopy.

M Colombat1, V Gounant, H Mal, P Callard, B Milleron.   

Abstract

Light chain deposition disease (LCDD) infrequently affects the lungs and usually causes damage to the parenchyma, while bronchial involvement appears to be very rare. The present authors report the case of a 64-yr-old female with LCDD characterised by asymptomatic airway involvement. Ten months after excision of a poorly differentiated vaginal carcinoma, a routine chest computed tomography (CT) scan revealed two lung cysts, several bilateral nodules and diffuse bronchial thickening. Pulmonary function tests were normal. Fibreoptic bronchoscopy showed marked diffuse mucosal thickening with highly conspicuous vascular plexuses. Nonamyloidal deposits were found in the bronchial wall, but no definite diagnosis could be proposed. On follow-up, the patient was still asymptomatic and the CT scan and endoscopic appearance remained unchanged. The final diagnosis of kappa LCDD was established 18 months later by another series of bronchial biopsies with frozen samples. Interestingly, electron microscopy showed dense granular deposits associated with nonamyloidal fibrils. An increased number of lung cysts were observed 32 months after identification of bronchial abnormalities, confirming the progressive nature of the disease. No extrapulmonary deposits or immunoproliferative disorder were found. In conclusion, light chain deposition disease, which may remain latent for several years, can entirely involve large airways and may be diagnosed by bronchial biopsy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470625     DOI: 10.1183/09031936.00134406

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

Review 1.  Diffuse Cystic Lung Disease. Part II.

Authors:  Nishant Gupta; Robert Vassallo; Kathryn A Wikenheiser-Brokamp; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2015-07-01       Impact factor: 21.405

2.  Natural history and outcome of light chain deposition disease.

Authors:  Rabya H Sayed; Ashutosh D Wechalekar; Janet A Gilbertson; Paul Bass; Shameem Mahmood; Sajitha Sachchithanantham; Marianna Fontana; Ketna Patel; Carol J Whelan; Helen J Lachmann; Philip N Hawkins; Julian D Gillmore
Journal:  Blood       Date:  2015-09-21       Impact factor: 22.113

Review 3.  Metastatic Angiosarcoma of the Scalp Presenting with Cystic Lung Lesions: A Case Report and Review of Cystic Lung Diseases.

Authors:  Antonette A Ajayi; Stephanie V Commins; David E Clarke
Journal:  Perm J       Date:  2018

4.  Amyloidosis involving the respiratory system: 5-year's experience of a multi-disciplinary group's activity.

Authors:  Raffaele Scala; Uberto Maccari; Chiara Madioni; Duccio Venezia; Lidia Calogera La Magra
Journal:  Ann Thorac Med       Date:  2015 Jul-Sep       Impact factor: 2.219

5.  Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPD.

Authors:  Judith A Hampson; Robert A Stockley; Alice M Turner
Journal:  Respir Res       Date:  2016-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.